LY3437943

Retatrutide in Canada: The Complete 2026 Guide to Status, Trials and Research Supply

Retatrutide has no Health Canada authorization and no Canadian submission on file, yet Canada hosts more than 115 of its trial sites. Where the triple agonist actually stands: what it is, what every published trial measured, why the headline numbers disagree, and how to tell a real research sample from a counterfeit.